Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 12 Lymphoma, Non-Hodgkin 9 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Arthritis, Rheumatoid 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia 2 Hematologic Neoplasms 2 Fallopian Tube Neoplasms 2 Cytokine Release Syndrome 2 Craniopharyngioma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 COVID-19 2

Interventions

upadacitinib 1 tocilizumab 1 acetaminophen, aspirin, caffeine drug combination 1 Vaccines 1 Transcutaneous Electric Nerve Stimulation 1 Saline Solution 1 Radiotherapy 1 Omeprazole 1 Nutrition Assessment 1 Naproxen 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lysine Acetyltransferase 5 1 Holistic Health 1 Herpes Zoster Vaccine 1 Febuxostat 1 Exergaming 1 Exercise Therapy 1 Collagenases 1 Colchicine 1 Blood Specimen Collection 1 Allopurinol 1 Adalimumab 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601611 2020-04-21

COLAR

Herlev Hospital

Phase NA Completed

Arthritis, Colitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡